UNSPSC 51142556: Melevodopa hydrochloride

This classification denotes a dopamine agonist with the molecular formula C10H13NO4.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JFU1A8866V. European Medicines Agency schedules melevodopa hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB33439. Most nations, for tariff and trade purposes, schedule melevodopa hydrochloride under HS 29225000. As of Q4 2014, MELEVODOPA HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: COC(=O)[C@H](CC1CCC(C(C1)O)O)N.CL.

UNSPSC 51142556 Melevodopa hydrochloride is a Commodity code that in practice does not align with recent state and local procurement activity. The single recent opportunity tagged to this code—Seminole County, Florida's IFB for naloxone and drug deactivation systems—involves acquisition of emergency medical countermeasures and harm-reduction equipment, not levodopa-based pharmaceutical products. The mismatch signals either a classification error in the opportunity posting or an outdated tagging convention at the issuing body. State and local procurement records show no other recent solicitations under this code.

Without aligned recent activity to characterize, the code presents no actionable opportunity profile. A business development professional sourcing levodopa hydrochloride or related anti-Parkinsonian pharmaceuticals for state and local health systems, correctional facilities, or public hospitals should monitor this code for potential reclassification or future activity, but current posting patterns do not support procurement planning under it.